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Solute carrier 41A3 encodes for a 
mitochondrial Mg2+ efflux system
Lucia Mastrototaro1, Alina Smorodchenko2, Jörg R. Aschenbach1, Martin Kolisek1 & 
Gerhard Sponder1
The important role of magnesium (Mg2+) in normal cellular physiology requires flexible, yet tightly 
regulated, intracellular Mg2+ homeostasis (IMH). However, only little is known about Mg2+ transporters 
of subcellular compartments such as mitochondria, despite their obvious importance for the deposition 
and reposition of intracellular Mg2+ pools. In particular, knowledge about mechanisms responsible 
for extrusion of Mg2+ from mitochondria is lacking. Based on circumstantial evidence, two possible 
mechanisms of Mg2+ release from mitochondria were predicted: (1) Mg2+ efflux coupled to ATP 
translocation via the ATP-Mg/Pi carrier, and (2) Mg2+ efflux via a H+/Mg2+ exchanger. Regardless, the 
identity of the H+-coupled Mg2+ efflux system is unknown. We demonstrate here that member A3 
of solute carrier (SLC) family 41 is a mitochondrial Mg2+ efflux system. Mitochondria of HEK293 cells 
overexpressing SLC41A3 exhibit a 60% increase in the extrusion of Mg2+ compared with control cells. 
This efflux mechanism is Na+-dependent and temperature sensitive. Our data identify SLC41A3 as 
the first mammalian mitochondrial Mg2+ efflux system, which greatly enhances our understanding of 
intracellular Mg2+ homeostasis.
The key role of magnesium (Mg2+) in a plethora of biochemical processes requires the tight regulation of intracel-
lular Mg2+ homeostasis (IMH). The intracellular Mg2+ concentration [Mg2+]i is regulated by the modulation of 
cellular uptake and efflux and by intracellular storage1. Several channels or transporters have been characterized 
as mediating the uptake of Mg2+ (e.g., TRPM6/7, MagT1, or NIPA1) or its extrusion (SLC41A1) across the cyto-
plasmic membrane2–5.
Member A1 of the solute carrier family 41 (SLC41A1; further referred to as A1) has been characterized as 
being a ubiquitous Na+-dependent Mg2+ efflux system integral to the plasma membrane6,5. Whereas the charac-
terization of plasma membrane-localised Mg2+ transporters is improving, the transporters for intracellular Mg2+ 
are largely unexplored. To date, the mitochondrial channel Mrs27,8 and Golgi-localised MMgt1/29 are the only 
known Mg2+ transport systems integral to membranes of subcellular compartments. Their discovery supports an 
earlier assumption that mitochondria, the endoplasmic reticulum (ER), and the Golgi apparatus serve as intra-
cellular Mg2+ stores10,11.
Kubota and colleagues have documented the release of Mg2+ from mitochondria upon their depolarization 
in PC12 cells10. Furthermore, long-chain fatty acids induce the rapid release of Mg2+ from rat liver mitochondria 
in alkaline media, presumably via an Mg2+/Me+ or an Mg2+/H+ exchanger12. Despite the increasing evidence in 
favour of such a mitochondrial exchanger (Mg2+ efflux system), its molecular identity in mammalian cells is as 
yet unknown. Recently, Cui et al. have characterized the protein Ymr166c/Mme1 (mitochondrial magnesium 
exporter 1) as the first known Mg2+ exporter in yeast mitochondria. Reconstitution experiments in proteoli-
posomes have shown that this transport activity is dependent on the presence of ATP, although ATP hydrolysis 
is not required. The authors therefore speculate that Mme1 acts as ATP/ATP-Mg exchanger13. In a subsequent 
study, the same group has identified the gene CG3476 as a Drosophila melanogaster orthologue of Mme1. The 
heterologous expression of CG3476 in yeast significantly reduces their mitochondrial Mg2+ levels. Knock-down 
or overexpression of the gene both reduces the viability of Drosophila. However, the precise mode of function of 
Ymr166c/Mme1 remains to be elucidated14.
The present study was based on the hypothesis that SLC41A3 can carry out Mg2+ export in eukaryotic cells, 
similarly to that of SLC41A1. Like the two other members of solute carrier family 41 (SLC41A1 and A2) SLC41A3 
contains two “MgtE-like domains” displaying homology to the prokaryotic Mg2+ transporter MgtE15,16. Human 
SLC41A3 has been mapped to chromosome 3q21.2–q21.3, and seven alternative splice variants are predicted to 
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be produced. The full-length protein consists of 507 amino acids with a molecular weight of 54.7 kDa. SLC41A3 
transcripts have been detected in various murine tissues, with the highest levels occurring in the central nervous 
system (in particular, in the neuronal cells of the cerebral cortex, the hippocampus, and lateral ventricle and in 
most cell types of the cerebellum)17. The anticipated importance of SLC41A3 (further referred to as A3) in CNS is 
further supported by the detection of neurological and behavioural abnormalities and, in particular, the abnormal 
locomotor coordination with ataxia, in the conditional knock-out mouse line Slc41a3tm1a(KOMP)Wtsi (http://www.
mousephenotype.org/). Furthermore, the expression of A3 is significantly increased in mice fed a Mg2+-deficient 
diet suggesting the importance of A3 for IMH18,19. The heterologous overexpression of A3 in Xenopus oocytes 
is associated with electrogenic Mg2+ conductance. These currents are saturable with a Km of 1.5 mM. Moreover, 
other ions have been identified as being transported via A3, a finding suggesting that A3 is an unspecific cat-
ion channel with a broad permeation profile20. The A3-specific electrogenic Mg2+ conductance seen in Xenopus 
oocytes has not been detected in mammalian cells. Sahni and colleagues have reported that A3 overexpressed in 
TRPM7-deficient B lymphocytes fails to restore normal Mg2+ homeostasis in these cells15.
We have therefore examined the cellular localisation of A3 and its ability to transport Mg2+. The presented 
data provide convincing evidence that SLC41A3 encodes a mitochondrial Mg2+ transporter responsible for the 
Na+-dependent efflux of the ion.
Results
Creation of tet-inducible HEK293 cell lines overexpressing SLC41A3. To study the function and 
cellular localisation of A3, a tet-inducible stably transfected cell line was newly generated expressing the protein 
with an N-terminal HA-Strep tag (A3st). At 24 hours after the addition of tetracycline, efficient inducible expres-
sion was detected by Western blot analysis with an antibody against the Strep tag (Fig. 1a, A3st). Furthermore, 
a HEK293 cell line stably expressing the tetracycline repressor (tetR) was constructed that served as a host for 
the regulated transient expression of A3. Wild-type HEK293 cells were transfected with the linearized plasmid 
pcDNA6/TR and cultured under blasticidin selection. Clones that stably expressed the tet repressor were subse-
quently transfected with the pcDNA5/TO-SLC41A3 construct and tested for their ability to down-regulate the 
expression of A3 in the absence of tetracycline. Amongst all transiently A3-expressing cell lines, “Clone2” (Cl2) 
exhibited the lowest level of A3 expression in the absence of tetracycline and abundant expression after induction 
and was therefore used for further experimentation (Fig. 1a). In contrast to Cl2, protein expression in HEK293 
wild-type cells transiently transfected with pcDNA5/TO-SLC41A3 (HEK WT) was independent of the presence 
of tetracycline due to the absence of the tet repressor (Fig. 1a). We furthermore sought to compare the expression 
levels of native and overexpressed A3. In parallel to the detection of overexpressed A3, the same samples were 
analysed on a parallel blot with an antibody directed against native A3 (Fig. 1b). Specificity of this antibody was 
confirmed in a blocking peptide competition assay (Supplemental Fig. S1). Immunodetection with the A3 anti-
body yielded two different signals, one for the monomeric form of untagged and one for the monomeric form of 
Strep-tagged A3. The apparent size difference is due to the HA-Strep tag which increases the molecular weight 
of SLC41A3 by approx. 4,3 kDa (Fig. 1b). Both antibodies furthermore detected high molecular weight signals 
between 100 and 250 kDa (Fig. 1a,b). These signals might arise from A3-containing, protein complexes that are 
Figure 1. Comparison of SLC41A3 protein levels in various HEK293 cell lines. HEK293 WT cells (HEK 
WT) or the HEK293 cell line with stably integrated Tet-repressor (Cl2) were transiently transfected with 
pcDNA5TO-SLC41A3 (− and + ) or the empty vector control (E). Protein expression in the transiently 
transfected cell lines (HEK WT and Cl2) and in the stably transfected cell line (A3st) was induced by addition 
of tetracycline to a final concentration of 1 μ g/ml (+ ). Uninduced control cells remained untreated (− ). Cells 
were harvested after 24 hours of induction and lysed in RIPA buffer. Total protein extracts were analyzed on an 
8.5% PAA-SDS gel and immunodetection of SLC41A3 (55 kDa) was either performed with an antibody directed 
against the Strep-tag (a) or against the native protein (b). The signals for the monomeric forms of native and 
Strep-tagged SLC41A3 are indicated. The ribosomal protein RPL19 (23 kDa) served as loading control and was 
detected by reprobing the membranes with the respective antibody.
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not readily dissolved in sample loading buffer. Alternatively, these signals might be A3 aggregates resulting from 
the strong overexpression of the protein.
SLC41A3 does not mediate Mg2+ transport across the plasma membrane but leads to an 
increase in the free cytoplasmic [Mg2+] when overexpressed. Member A1 of solute carrier family 41 
has been extensively characterized as the major Mg2+-extrusion system in the plasma membrane6,5,21. The amino 
acid sequences of A1 and A3 display 56.3% sequence identity and 72.7% sequence similarity (calculated with 
EMBOSS 6.3.1:matcher, http://mobyle.pasteur.fr/cgi-bin/portal.py?#forms::matcher), respectively. According to 
the prediction program PSORTII (http://psort.hgc.jp/), the probability for the plasma membrane localisation 
of A3 is 78.3%, and only 21.7% for its localisation in the endoplasmic reticulum. Based on these data, a func-
tional similarity to the well-characterized plasma membrane Na+/Mg2+ exchanger A1 was assumed. To examine 
the anticipated function of A3, we investigated the effect of A3 overexpression on Mg2+ fluxes in intact cells. 
By using the Mg2+-sensitive fluorescent dye mag-fura 2, we first examined the ability of SLC41A3 to mediate 
Mg2+ extrusion (efflux condition). Cells were loaded with mag-fura 2 and subsequently incubated in a buffer 
solution containing 10 mM MgCl2 for 20 min. Thereafter, the Mg2+-fluxes were measured over a time period of 
1,200 s in nominally Mg2+-free buffer solution containing 145 mM NaCl. Surprisingly, induced cells of the stable 
cell line (A3st + tet) and of the transiently transfected cells (Cl2/A3 + tet) did not exhibit Mg2+ extrusion but 
rather an increase in [Mg2+]i of 0.26 ± 0.04 and 0.20 ± 0.05 mM/1,200 s (Fig. 2a,b), respectively. In contrast, unin-
duced A3st (A3st −tet; 0.11 ± 0.02 mM/1,000 s), transiently transfected uninduced Cl2/A3 cells (Cl2/A3 −tet; 
0.10 ± 0.02 mM/1,000 s), and wild-type HEK293 cells (HEK WT; 0.05 ± 0.04 mM/1,000 s) exhibited significantly 
lower changes of [Mg2+]i (P < 0.05). These data indicate that the increase in [Mg2+]i in induced cells was A3 
related. Given that the experiments were carried out in completely Mg2+-free buffer solution, the increase in the 
cytoplasmic free Mg2+ concentration in SLC41A3-overexpressing cells could not have been caused by Mg2+ influx 
across the plasma membrane.
Figure 2. Effect of the expression of SLC41A3 on the change of the intracellular free magnesium 
concentration (Δ[Mg2+]i) in HEK293 cells. (a) Tetracycline-induced (+ tet) and uninduced (− tet) cells of 
the SLC41A3 overexpressing cell lines A3st (stable A3 expression) and Clone2 (transient A3 expression) were 
loaded with Mg2+, and changes of [Mg2+]i after 1,200 s in completely Mg2+-free solution were determined. 
Wild-type HEK293 cells (HEK WT) served as a control. Values are given as means ± SEM. Number of 
measurements: NA3 −tet = 17; NA3 +tet = 12; NCl2/A3 −tet = 10; NCl2/A3 +tet = 10; NHEK WT = 6. a,bColumns with 
different letters differ significantly in pairwise comparisons. (P < 0.05). (b) Representative original recordings of 
[Mg2+]i changes of Mg2+ -preloaded cells measured in completely Mg2+-free external buffer solution.
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To substantiate the inability of SLC41A3 to mediate flux of Mg2+ across the plasma membrane, Mg2+ influx 
experiments were performed. A3st cells were induced with tetracycline for 24 hours or left untreated and loaded 
with mag-fura 2. Subsequently, [Mg2+]i was measured over a period of 400 s in which Mg2+ was added stepwise 
to final extracellular concentrations of 1, 3 and 5 mM. The shorter duration of 400 s was chosen to minimize the 
release of Mg2+ from intracellular stores. Representative curves for HEK293 cells overexpressing SLC41A3 and 
for uninduced control cells are shown in Fig. 3a. As expected, in the presence of an inwardly directed Mg2+ gra-
dient, −tet and + tet A3st cells exhibited the uptake of the ion into the cell. However, the overexpression of the 
protein did not result in a significantly different uptake capacity (Fig. 3b), implying that SLC41A3 did not medi-
ate the influx of Mg2+ across the plasma membrane under our experimental conditions. Thus, the only logical 
explanation is that, in response to the overexpression of SLC41A3, Mg2+ stored in organelles is released, thereby 
increasing the cytoplasmic Mg2+ concentration.
SLC41A3 is a mitochondrial protein. Next, we performed subcellular fractionation using the Qproteome 
cell compartment kit (Qiagen) to assess the localisation of SLC41A3 within the cell. In uninduced A3st cells 
(−tet) a band of ~55 kDa corresponding to A3 was almost exclusively detected in the membrane fraction when 
using an antibody recognizing native A3 (M; Fig. 4). In induced A3st cells (+ tet) detection with the native anti-
body yielded two signals, one for native A3 and one for the overexpressed Strep-tagged protein. In addition, a 
weak signal was detected in the fraction containing soluble proteins (C); this signal might have been caused by 
minor contamination during the sequential isolation of the various fractions. No signal for SLC41A3 was detected 
in the fractions enriched for nuclear (N) or cytoskeletal proteins (fraction S; Fig. 4). The specificity of the frac-
tionation process was controlled by probing parallel blots with antibodies against the cytosolic ribosomal protein 
(RP)L19 (fraction S) and the plasma membrane protein PMCA4 (membrane fraction, M). The cytosolic protein 
RPL19 was detected only in the soluble protein fraction, and the plasma membrane Ca2+ ATPase PMCA4 was 
found, as expected, in the membrane fraction. These data clearly characterize SLC41A3 as being a membrane 
protein.
As mentioned above, SLC41A3 is predicted to be most likely targeted to the plasma membrane and less prob-
ably to the ER. To clarify further the subcellular localisation of SLC41A3 and to exclude potential targeting to the 
ER, we used an ER isolation kit (Fig. 5a). Various organelle marker proteins were used to control the specificity of 
the isolation process: Golgin-97 as a Golgi marker, ERp72 for the ER, and COX IV for mitochondria. Most impor-
tantly, the experiment was performed with wild-type HEK293 cells, and only endogenous levels of SLC41A3 
were detected with an antibody directed against the native protein. As shown in Fig. 5a, various fractions were 
collected during the differential centrifugation process. SLC41A3 was predominantly detected in fraction M, 
which mainly contained mitochondrial membranes as verified by the strong signal for COX IV in this fraction. A 
signal for SLC41A3 was also observed in fraction P1, which contained unbroken cells and plasma membrane. The 
highly pure ER fraction did not contain SLC41A3. Golgi vesicles were mainly found in fraction SN, which also 
did not overlap with the signal for native SLC41A3. Taken together, these data clearly argue for the localisation 
of SLC41A3 in mitochondria and exclude that the protein is targeted to the ER under physiological expression 
levels.
Next, we sought to confirm the cellular distribution of A3 by fluorescence microscopy. To this end, we per-
formed double-stain immunofluorescence with an antibody directed against the native protein together with 
an antibody against the mitochondrial marker protein COX IV. Induced and uninduced A3st cells were used to 
Figure 3. Overexpression of SLC41A3 does not alter the Mg2+ uptake capacity across the plasma 
membrane in HEK293 cells. (a) Tetracycline-induced (+ tet) or uninduced (− tet) A3st cells were loaded with 
mag-fura 2, and measurements were carried out in completely Mg2+-free buffer solution to which Mg2+ was 
added after 100 s (1 mM), 200 s (3 mM), and 300 s (5 mM final concentration). (b) Changes in the intracellular 
Mg2+ concentration (∆ [Mg2+]I), calculated from averaged concentrations of the first and the last 50 s of the 
measurement, were 0.34 mM ± 0.03 for uninduced control cells and 0.30 ± 0.03 mM for induced cells. (n.s., not 
significant).
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detect potential mistargeting and any aberrant localisation within the cell attributable to the overexpression of the 
protein (Fig. 6). Strong colocalisation of the two signals was observed in A3st + tet and notably also in A3st −tet 
cells. These data confirm our previous observations and again suggest that A3 is targeted to mitochondria, both 
when overexpressed and when under the control of its endogenous promoter. Furthermore, we performed 
Figure 4. Immunodetection of SLC41A3 after subcellular fractionation. Cytosolic (C), membrane (M), 
nuclear (N), and cytoskeletal (S) protein-enriched fractions were isolated from −tet and + tet A3st cells and 
analysed by Western blot. Immunodetection was performed with an antibody directed against native SLC41A3. 
Immunosignals were detected exclusively in the membrane protein fraction (M) in −tet cells as a single band 
corresponding to the native protein and, in + tet cells, as two bands corresponding to native and Strep-tagged 
SLC41A3, respectively. To confirm the specificity of the fractionation, PMCA4 was used as a control for the 
membrane fraction (M) and RPL19 for the cytoplasmic protein fraction (C).
Figure 5. SLC41A3 is primarily localised in mitochondria. (a) Western blot analysis of the total protein 
fraction (T) and the various fractions (pellet 1, P1; supernatant, SN; mitochondrial pellet, M; endoplasmic 
reticulum, ER) obtained by using an ER isolation kit and differential centrifugation. SLC41A3 was detected 
with an antibody recognizing the native protein. Golgin-97 served as a Golgi marker, ERp72 as a marker for 
the ER, and COX IV for mitochondria. (b) A mitochondria isolation kit (Sigma-Aldrich) was used to isolate 
mitochondria-enriched fractions of wild-type HEK293 cells (HEK WT) and of tetracycline-induced A3st (A3st 
+ tet) cells. The total protein fraction (T) was obtained by solubilizing intact cells. The second fraction and third 
fractions (ML and MH) were enriched in mitochondria. The more purified “heavy” fraction MH was obtained 
by low-speed centrifugation (3,500 g), whereas the light ML fraction was isolated by high-speed centrifugation 
(11,000 g). The antibody recognizing native SLC41A3 was used to detect the protein in fractions obtained from 
HEK WT cells. An anti-Strep antibody was used for the detection of overexpressed SLC41A3 in fractions of 
A3st + tet cells. Respiratory chain complex IV (COX IV) served as a mitochondrial loading control and the 
soluble protein RPL19 for the total protein fraction.
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double-stain immunofluorescence in uninduced and induced A3st cells with the anti-Strep antibody in combina-
tion with either the mitochondrial marker COX IV, ERp72 for the endoplasmic reticulum or Glogin-97 as Golgi 
marker. These results are summarized in Supplemental Figs S2–S4. Similar to the results obtained with the native 
antibody, significant colocalisation was only observed with the mitochondrial protein COX IV (Supplemental 
Fig. S2).
Finally, we directly isolated mitochondria from HEK WT and A3st + tet cells. After the homogenization step, 
the obtained suspension was first centrifuged at low speed (3,500 rpm) to obtain a more purified fraction of 
“heavy” mitochondria. The remaining supernatant was then centrifuged at high speed (10,000 rpm) to yield a 
fraction enriched in “light” mitochondria. Both fractions were analysed by Western blot, together with the total 
protein extract. The inner mitochondrial membrane protein COX IV was used as a marker protein to control the 
specificity of the fractionation process. In the fractions obtained from HEK WT cells, A3 was detected in the two 
mitochondrial fractions with the antibody recognizing the native protein and was clearly enriched, in particular, 
in the purer “heavy” mitochondrial fraction compared with the total protein extract (Fig. 5b). In A3st + tet cells, 
overexpressed A3 was detected with the anti-Strep antibody. The fact that Strep-tagged A3 is enriched particu-
larly in the “heavy” mitochondrial fraction confirmed that also the overexpressed protein is efficiently target to 
mitochondria.
Overexpression of SLC41A3 increases the efflux of Mg2+ from mitochondria. The above presented 
data clearly argue for the mitochondrial localisation of SLC41A3 and open up the possibility that the protein 
functions as a Mg2+ extrusion system in the inner mitochondrial membrane. To test this hypothesis, we estab-
lished a “Mg2+-loading” protocol for isolated, respiring mitochondria similar to that used successfully to study the 
function of SLC41A1 in whole cells6,5. Mitochondrial Mg2+ loading takes advantage of the strong inside-negative 
membrane potential of − 150 to − 180 mV that is the major driving force for the high capacity Mg2+ uptake 
system, the Mg2+-selective channel Mrs2. Incubation of isolated respiring mitochondria in Mg2+-containing 
buffer solutions results in the rapid regulated uptake of the ion. Accordingly, we made use of the observation 
that isolated mitochondria can be efficiently “loaded” with Mg2+ 7 and investigated the effect of overexpression of 
SLC41A3 on the Mg2+ efflux capacity out of the organelle (Fig. 7a,b). Isolated mitochondria were first loaded with 
the membrane-permeable acetoxymethyl ester (AM) of mag-fura 2 in the presence of 10 mM MgCl2, followed 
by an activation/loading step. During the latter step, the dye was activated by intra-organellar esterases in the 
presence of MgCl2. The intramitochondrial free Mg2+-concentration [Mg2+]m was then determined over a time 
Figure 6. Fluorescence visualization of mitochondrial SLC41A3 localisation. Triple-staining with 
anti-SLC41A3 antibody (red), anti-COX IV antibody (green) and DAPI (Blue, ony shown in merged) was 
performed. The merged picture shows that immunosignals for SLC41A3 and COX IV colocalised in uninduced 
(A3st − tet) and induced (A3st + tet) cells with a stronger intensity upon tetracycline induction.
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period of 1,000 s in nominally Mg2+-free buffer solution. After the 1,000 s efflux period, Mg2+ was added to give 
a final concentration of 5 mM in order to demonstrate that the mitochondria maintained their vitality and were 
able to rapidly increase their free [Mg2+]m upon external Mg2+ exposure. Figure 7b shows representative curves 
for mitochondria isolated from overexpressing cells and control cells, whereas Fig. 7a shows summarized data for 
Δ [Mg2+]m over the efflux period. Overexpression of SLC41A3 significantly (P < 0.01) increased the efflux capac-
ity by ~55% compared with control cells (− 0.43 ± 0.07 mM/1,000 s vs. − 0.18 ± 0.08 mM/1,000 s). Moreover, the 
higher rate of Mg2+ efflux was also reflected by the lower free [Mg2+]m at the start of each efflux measurement. 
The starting [Mg2+]m (value calculated as the average of the first 50 s of each measurement) of mitochondria 
isolated from SLC41A3 overexpressing cells was significantly (P < 0.05) reduced by 21.2% compared with that 
of uninduced control cells. This indicates that the mitochondria of SLC41A3 overexpressing cells are loaded less 
effectively with Mg2+ because of a stronger activity of the extrusion system.
Mg2+ efflux from mitochondria overexpressing SLC41A3 is dependent on the presence of Na+. 
Interestingly, the SLC41A3-dependent increase in the efflux capacity was only observed when 10 mM NaCl was 
present in the external buffer solution. In NaCl-free buffer solution, the efflux capacity of mitochondria isolated 
from induced cells (− 0.15 ± 0.11 mM/1,000 s) was reduced to levels comparable with that of uninduced control 
mitochondria (Fig. 7). To investigate further the role of Na+ in Mg2+ extrusion, we performed efflux measure-
ments in the presence of various NaCl concentrations (Fig. 8). Increasing the Na+ concentration in the meas-
urement buffer solution to 20 and 40 mM resulted in higher Mg2+ extrusion rates compared with measurements 
performed in the presence of 10 mM NaCl (Fig. 8b). As shown in Fig. 8a, when Mg2+ efflux in the presence of 
10 mM NaCl was set at 100%, the presence of 20 mM or 40 mM NaCl in the buffer solution increased the efflux 
capacity to 177 ± 21% and 246 ± 45%, respectively (P < 0.01). Next, we investigated the effect of replacing Na+ in 
the measurement solution with N-methyl-D-glucamine (NMDG). The presence of 10 mM NMDG-Cl instead of 
10 mM NaCl almost abolished the Mg2+ efflux capacity of mitochondria (34.5 ± 7.9%).
SLC41A3-mediated Mg2+ efflux is temperature-sensitive but not affected by imipramine. We 
furthermore investigated whether imipramine, a known inhibitor of Na+/Mg2+ exchange mediated via SLC41A15, 
Figure 7. Effect of the overexpression of SLC41A3 on the mitochondrial free magnesium concentration 
([Mg2+]m) in HEK293 cells. (a) Mitochondria of tetracycline-induced (+ tet) and uninduced (− tet) cells of 
the SLC41A3 stable cell line A3st were loaded with Mg2+, and changes of [Mg2+]m during 1,000 s in completely 
Mg2+-free solution were determined. All solutions contained 10 mM NaCl, except solution + tet without NaCl. 
The imipramine concentration was 250 μ M. Values are given as means ± SEM. Number of measurements: NA3 
−tet (10 mM NaCl) = 12; NA3 +tet+imip = 6; NA3 +tet (without NaCl) = 5; NA3 −tet = 13; a,bColumns with different letters differ 
significantly in pairwise comparisons (P < 0.01). (b) Representative original recordings of [Mg2+]m changes of 
isolated mitochondria in completely Mg2+-free medium with or without Na+ in the external buffer solution. 
Before the measurements, mitochondria were loaded with Mg2+ by incubating them in Mg2+-containing buffer 
solution (10 mM) for 20 min. Imipramine (imip) was added to the buffer solution directly before measurements 
were recorded. After 1,000 s, MgCl2 was added to give a final concentration of 5 mM, resulting in a steep 
increase of the mitochondrial [Mg2+].
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affected Mg2+ extrusion from mitochondria isolated from cells overexpressing SLC41A3. Under our experimental 
conditions, the application of 250 μ M imipramine did not reduce the efflux capacity (Fig. 7). Finally, we tested 
whether the observed Mg2+ efflux was sensitive to changes in incubation temperature. At the lower temperature 
of 16 °C, Mg2+ efflux from mitochondria was almost completely abolished and was similar to that of mitochondria 
incubated in the absence of Na+ (Fig. 8).
The effect of SLC41A3 overexpression on cellular ATP levels under Mg2+ starvation conditions. 
To get a first insight into the physiological role of SLC41A3 we investigated the effect of A3 overexpression in 
complete medium and under conditions of reduced Mg2+ availability on the total levels of cellular ATP. As cells 
under culture conditions usually exhibit a high glycolytic activity, thereby masking a potential mitochondrial 
dysfunction, cells were forced to switch to mitochondrial respiration by replacing glucose/glutamine by galactose/
glutamine. A3st cells were seeded and grown for 24 h in DMEM/Gal medium. Thereafter, expression of A3 was 
induced by addition of tetracycline for another 24 h. The DMEM/Gal medium was then exchanged either for 
HBSS medium with 0.8 mM MgSO4 or for HBSS medium without MgSO4. Control cells remained in DMEM/Gal 
medium. After an incubation period of 8 h a luminescence based assay was performed to determine cellular ATP 
Figure 8. SLC41A3-mediated efflux of Mg2+ is dependent on the Na+ concentration in the external buffer 
solution and is temperature-sensitive. (a) Mitochondria of tetracycline-induced (+ tet) cells of the SLC41A3 
stable cell line were loaded with mag-fura2 and Mg2+, and the changes of [Mg2+]m during 1,000 s in completely 
Mg2+-free solution were determined. The external buffer solution contained various concentrations of NaCl. 
Values obtained with 10 mM NaCl were set as 100% efflux activity. The efflux capacity increased with increasing 
NaCl concentrations in the measurement solution. Mitochondria measured at 16 °C exhibited a strongly 
reduced efflux of Mg2+. Similarly, replacement of NaCl with NMDG significantly reduced Mg2+ extrusion to 
approx. 34% of the standard efflux activity. Values are given as means ± SEM. Number of measurements: N10 mM 
NaCl = 9; N20 mM NaCl = 7; N40 mM NaCl = 7; N10 mM NMDG = 5; N10 mM NaCl (RT) 5. a,b,c,dColumns with different letters differ 
significantly in pairwise comparisons (P < 0.01). (b) Representative original recordings of [Mg2+]m changes of 
isolated mitochondria in completely Mg2+-free medium with various concentrations of NaCl in the external 
measurement medium. N-Methyl-D-glucamine (NMDG) was used to replace sodium in the measurement 
buffer.
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levels. As shown in Supplemental Fig. S5, relative ATP levels of A3st cells continuously grown in DMEM/Gal or 
incubated for 8 h in Mg2+-containing HBSS medium were unaffected by the expression level of A3. In contrast, 
cells overexpressing A3 exhibited lower cellular ATP levels than uninduced cells if cultured under Mg limiting 
conditions. However, due to the high inter-assay variability in luminescence counts the observed reduction in 
cellular ATP was statistically not significant. Nevertheless, these data imply that overexpression of A3 has a strong 
tendency to impair mitochondrial ATP production by reducing the Mg2+ availability in mitochondria.
Discussion
Magnesium is vital for normal cellular bioenergetics. In mitochondria, Mg2+ not only chelates and stabilizes 
ATP, but also serves as a cofactor of enzymes involved in cellular respiration and energy production22. Moreover, 
isolated, energized mitochondria are able to accumulate Mg2+ up to concentrations that are 3 to 5 times higher 
than those in cytoplasm7. Mg2+ has been demonstrated to permeate into the mitochondrial matrix via the 
high-conductance channel Mrs2, which is powered by a steep negative membrane potential on the inner mito-
chondrial membrane7.
The demonstration that Mrs2 constitutes a major mitochondrial Mg2+ influx system adds the desired molec-
ular ratio to the formerly proposed hypothesis that mitochondria represent the major intracellular Mg2+ storage 
compartment7,8,10,23. Mitochondria must therefore be a dynamic, tightly regulated, open system able not only to 
accumulate, but also to release Mg2+. Salvi et al. demonstrated that besides inducing mitochondrial permeability 
transition, gliotoxin activates a specific Mg2+ efflux system in brain mitochondria24. To date, two possible mech-
anisms of Mg2+ release from mitochondria have been suggested: (1) a Mg2+ transport (efflux) coupled to ATP 
translocation via an ATP-MgPi carrier (APC)25–27, and (2) a Mg2+ efflux system powered by H+ motive force23,28,29.
The H+ gradient perpetually building-up on the inner mitochondrial membrane represents the major motive 
force powering the transport of various solutes across the inner mitochondrial membrane. The Na+ contribution 
to the generation of the membrane potential on the inner mitochondrial membrane is thought to be only sec-
ondary. However, the role of Na+ in the transport physiology of mitochondria is indisputable. Na+ homeostasis 
in mitochondria is governed by transport mechanisms such as the Na+/H+ exchanger (mNHE, Na+ efflux mech-
anism30), Na+-HCO3− symporter (mNHCO3 (SLC4A7), Na+ influx mechanism31), and the Na+/Ca2+ exchanger 
(mNCE, Na+ influx mechanism32). The paucity of data on the matrix Na+ homeostasis in respiring mitochondria 
leaves the field largely unexplored. Jung et al. have reported that, in isolated respiring mitochondria, the [Na+]m 
is approximately 1/8 of that in the cytosol30. However, the gradient might be less pronounced for mitochondria 
in situ33. Nevertheless, studies of permeabilized cardiac myocytes have confirmed that the matrix [Na+]m is lower 
than cytosolic [Na+]i in energized mitochondria30,34.
In metabolically inhibited, non-permeabilized MDCK cells, [Na+]m reaches striking 113 + /− 7 mM, which 
is approximately double the concentration of Na+ in the cytoplasm of the same cells35. The accumulated Na+ is 
then used to “fuel” the influx of Ca2+ via mNCE into the mitochondria35. This study has shown that mitochon-
dria possess a large potential to accumulate Na+ that can be used to support the transport of other solutes via 
Na+-dependent transport mechanisms under various physiological and pathophysiological situations.
Our data unequivocally demonstrate that SLC41A3 is a protein integral to the inner mitochondrial membrane 
and that it functions as an Mg2+ efflux system coupled with the influx of Na+. Based on its similarity with mem-
ber A1 of the same protein family, namely a Na+/Mg2+ exchanger integral to the cytoplasmic membrane, we can 
assume that the coupling between the Mg2+ efflux conducted via SLC41A3 and the Na+ influx is direct; however, 
further thorough experiments must be carried out to support this notion. Moreover, we observed a strong tem-
perature dependence of the Mg2+ extrusion process mediated by SLC41A3. Reducing the incubation tempera-
ture to 16 °C lowered the efflux capacity by ~85% compared with measurements performed at 37 °C. A similar 
reduction was also observed for the plasma membrane Na+/Mg2+ exchanger SLC41A16. In contrast, Mg2+ influx 
mediated by the high-conductance channel Mrs2 is entirely insensitive to a reduction of the temperature7. This 
is a further indication that the transport conducted by SLC41A3 is a carrier/exchange mechanism. Interestingly, 
application of the Na+/Mg2+ transport inhibitor imipramine had no effect on the SLC41A3-based Mg2+ efflux 
from mitochondria. This is surprising, since imipramine is a potent inhibitor of the plasma membrane localised 
Na+/Mg2+ exchanger SLC41A15. However, it can be explained either by stereochemical differences between the 
Na+-binding sites in SLC4A1 and in SLC41A3, or by indirect coupling of SLC41A3-mediated Mg2+ efflux to Na+ 
counter-transport. This issue will need further examination.
Many degenerative diseases are hallmarked by a deranged Mg homeostasis at both the cellular and organism 
levels36. In particular, diseases that belong to hereditary or age-related mitopathies have been demonstrated to 
be characterized by aberrant mitochondrial homeostasis and the consequent loss of control over cellular energy 
turnover (e.g., Alzheimer’s and Parkinson´s diseases, diabetes mellitus type 2, schizophrenia). Furthermore, 
these diseases are often associated with Mg deficiency36–42. To date, the mitochondrial Mg2+ channel Mrs2 is the 
only transport mechanism that might link Mg deficiency with disturbed mitochondrial homeostasis43. Indeed, 
Kuramoto et al. have found that the abrogation of Mrs2 function in the CNS of rats causes massive demyeli-
nation and have concluded that normal mitochondrial Mg2+ homeostasis is essential for the maintenance of 
myelin and, thus, CNS functions44. Mastrototaro et al. have recently suggested a role of the insulin signalling 
cascade in the regulation of cellular magnesium homeostasis via the Na+/Mg2+ exchanger SLC41A1 and also via 
an early onset of Mg2+ efflux from intracellular stores, such as mitochondria, the Golgi apparatus, and the endo-
plasmic reticulum45. However, no molecular mechanism could be proposed to explain the efflux of Mg2+ from 
mitochondria. The discovery of SLC41A3 as a mitochondrial Na+-dependent Mg2+-efflux system now offers the 
possibility to examine further the effect of insulin on the deposition and reposition of Mg2+ under normal and 
also pathological (diabetic) conditions. Further research on SLC41A3 will lead to the better understanding of 
the orchestration between extramitochondrial and intramitochondrial Mg homeostasis and their interrelation-
ship with the energy metabolism of the cell. The observation that under Mg2+ starvation conditions ATP levels 
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are reduced in SLC41A3 overexpressing cells, suggests an important role of SLC41A3 in mitochondrial energy 
metabolism. We hypothesise that the joint activity of the Mg2+ influx system Mrs2 and the Mg2+ efflux system 
SLC41A3 plays a central role for Mg2+ homeostasis in mitochondria. This might be of particular importance for 
improving the therapeutic strategies and management of age-related mitopathies with simple measures such as 
Mg supplementation.
Materials and Methods
Cell line generation, growth media, and cell culture. To study the localisation and function of 
SLC41A3, a tetracyclin-(tet)-inducible stably transfected cell line (A3st) was constructed in cooperation with 
DualSystems Biotech (Schlieren, Switzerland). Briefly, full-length human SLC41A3 cDNA was cloned into the 
pNTGSH expression vector with an N-terminal HA-Strep tag. The pNTGSH-HA-Strep-SLC41A3 was electropo-
rated into the Flp-In™ T-REx™ HEK293 cell line (Life Technologies, Darmstadt, Germany) and recombined into 
a defined genomic integration locus that was inserted into the host cell line. Cells were placed under hygromycin 
B (Hyg) and blasticidin S (Bla) selection in order to select for cells containing the integrated expression construct. 
Stable resistant clones were harvested and seeded in fresh medium containing Hyg and Bla and finally screened 
for tet-inducible expression of the HA-Strep-tagged SLC41A3.
The tet-inducible HEK293 cells with stably integrated SLC41A3 were grown at 37 °C under a 5% CO2 atmos-
phere in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, 1% penicillin/streptomycin 
(Pen/Strep), 15 μ g/mL Bla, and 100 μ g/mL Hyg.
To confirm the results obtained in the genetically modified SLC41A3-HEK293 cells, a cell line transiently 
expressing SLC41A3 was constructed by using the pcDNA5/TO vector system (Life Technologies, Darmstadt, 
Germany), which allowed tet-inducible expression.
First, HEK293 cells were stably transfected with the plasmid pcDNA6/TR in order to generate a host cell 
line constitutively expressing the tet-repressor protein. This plasmid also included the Bla resistance gene under 
the control of the SV40 promoter; expression of this gene allowed the selection of cells stably transfected with 
the plasmids. We first determined the minimum Bla concentration necessary to kill wild-type HEK 293 cells 
within 20 days. The selective medium was replenished every 3 days for a time period of 20 days. The appropri-
ate Bla concentration for our HEK 293 cell line was determined to be 15 μ g/mL. In the next step, HEK 293 cells 
were transfected with pcDNA6/TR by using the transfection reagent polyethylenimine (PEI). At 48 hours after 
the transfection, the cells were serially diluted to obtain single clones able to grow in medium containing Bla 
(15 μ g/mL). Colonies formed under Bla selection integrated the vector stably into their genome and expressed the 
tet-repressor gene. Several cell foci were picked, further expanded, and tested for tet-inducible gene expression 
by transiently transfecting them with pcDNA5/TO-SLC41A3. The clone, termed “Clone 2 (Cl2/A3)”, showed the 
well-regulated expression of SLC41A3 (low background expression in the absence of tet and significant induction 
of expression upon tet addition).
Cl2/A3 cells were grown at 37 °C and under a 5% CO2 atmosphere in DMEM supplemented with 10% FBS, 
1% Pen/Strep, and 15 μ g/mL Bla.
Cloning of SLC41A3 into pcDNA™5/TO. The human gene SLC41A3 was synthetized with an 
N-terminal HA-Strep tag and cloned via 5′ KpnI and 3′ NotI into the expression vector pcDNA™ 5/TO under the 
control of a tet-inducible promoter.
Protein expression and Western blot. SLC41A3 protein expression was induced by the addition of 
1 μ g/mL tet for 24 hours. After induction, cells were harvested, washed twice in ice-cold phosphate-buffered 
saline (PBS) and resuspended in lysis buffer (50 mM Tris HCl pH 8.0, 150 mM sodium chloride, 1.2% Triton 
X-100, 0.1% SDS, 1 mM EDTA, and protease inhibitor cocktail (cOmplete mini, EDTA-free, Roche Diagnostics)). 
Lysis was performed for 20 min at 4 °C with gentle agitation followed by a clarifying spin (20 min, 14,000 rpm, 
4 °C). The supernatant was then resolved on a 10% polyacrylamide-gel (SDS-PAGE). Following electrophoresis, 
semi-dry blotting to a polyvinylidene difluoride (PVDF) membrane was performed. A primary mouse antibody 
directed against the Strep-tag (1:2,500, Qiagen, Hilden, Germany) or a rabbit antibody against the N-terminus of 
native SLC41A3 (Santa Cruz Biotechnology, Heidelberg, Germany) in combination with the respective horserad-
ish peroxidase (HRP)-conjugated secondary antibodies (anti-mouse, 1:1,000; anti-rabbit, 1:2,000; both from Cell 
Signaling Technology, Frankfurt, Germany) were used to detect SLC41A3. Proteins were visualized by use of the 
SuperSignalTM West Dura system (Pierce, Dreieich, Germany).
Blocking peptide competition assay with the antibody recognizing native SLC41A3. The 
SLC41A3-specific rabbit antibody was purchased from Santa Cruz Biotechnology (Heidelberg, Germany) 
together with the blocking peptide. To test the specificity of the antibody a competition assay was performed. 
Total protein samples (5 and 15 μ g) of HEK293 wild type cells and of induced A3st cells were separated in trip-
licate on two 8.5% SDS-PAA gels and blotted to a PVDF membrane. Each membrane was cut into three strips. 
The first strip was incubated with the SLC41A3-specific antibody at a concentration of 0.125 μ g/μ l in 2.5% milk/
TBS-T. The second strip was incubated in a mixture of anti-SLC41A3 antibody (0.125 μ g/ml) and blocking pep-
tide (0.25 μ g/μ l). The third membrane strip was incubated with a mixture of anti-SLC41A3 antibody and blocking 
peptide with the concentrations mentioned above together with anti-Strep antibody (0.8 μ g/μ l). After over-night 
incubation of the membranes with the primary antibody, one membrane was incubated with the anti-rabbit 
secondary antibody (dilution: 1:2,000, suitable for the anti-SLC41A3 antibody); the second membrane was incu-
bated with the secondary anti-mouse antibody (dilution 1:1,000, suitable for the primary anti-Strep antibody). 
Proteins were visualized by use of the Clarity™ Western ECL Blotting Substrate (Bio-Rad, Munich, Germany).
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Gross cell-compartment specific localisation of SLC41A3. The Qproteome Cell Compartment Kit 
(Qiagen) was used according to the manufacturer’s instructions to isolate sequentially the proteins associated 
with the cytosol, nucleus, cellular membranes, or cytoskeleton. The various fractions were analysed by Western 
blotting. For detection of SLC41A3, the above-described antibody recognizing the native protein was used. 
Specificity of the isolation was controlled with a mouse antibody against the cytosolic marker protein RPL19 
(cytosolic ribosomal protein (RP)L19, Abnova, Heidelberg, Germany) and a mouse antibody directed against the 
plasma membrane Ca2+-ATPase (PMCA4, Sigma-Aldrich, Munich, Germany). Secondary antibodies were the 
same as those mentioned above.
Isolation of various cellular membranes/organelles from HEK293 cells. The Endoplasmic 
Reticulum Isolation Kit (Sigma-Aldrich, Munich, Germany) was used for the isolation of intracellular organelles 
by differential centrifugation. The experiments were performed according to the manufacturer’s protocol. In brief, 
3 × 108 wild-type HEK293 cells were collected and washed with PBS. Cells were first resuspended in hypotonic 
extraction buffer, incubated for 20 min at 4 °C, and centrifuged again. The pellet was resuspended in isotonic 
extraction buffer, and cells were homogenized by using a Dounce homogenizer. An aliquot of the homogenate 
was saved for Western blot analysis (total protein fraction in Fig. 5a). The homogenate was centrifuged at 1,000 g 
and 4 °C for 10 min. The post-nuclear supernatant was transferred to a new tube. An aliquot was stored for later 
analysis (fraction SN in Fig. 5a). The remaining supernatant was centrifuged at 12,000 g and 4 °C for 15 min. The 
supernatant represented the post-mitochondrial fraction, whereas the pellet contained the mitochondrial mem-
branes. The pellet was therefore stored for protein extraction and further analysis (fraction M in Fig. 5a). From 
the post-mitochondrial supernatant, ER-enriched microsomes were prepared by CaCl2 precipitation according 
to the protocol (fraction ER in Fig. 5a). For Western blot analysis, supernatant fractions were mixed with 4× 
SDS-sample buffer, and proteins from the pellet fractions were extracted with standard RIPA buffer. Proteins 
were resolved on 10% polyacrylamide-gels (SDS-PAGE) and blotted to polyvinylidene difluoride (PVDF) mem-
branes. The above-described rabbit antibody was used for detecting native SLC41A3. Antibodies for controlling 
the specificity of the fractionation were: Golgin-97 as a Golgi network marker, protein disulphide isomerase fam-
ily A member 4 (ERp72) as an ER marker, and cytochrome c oxidase (COX IV) for mitochondria (all from Cell 
Signaling Technology, Frankfurt, Germany). Secondary antibodies were used as mentioned above.
Isolation of mitochondria for protein analysis. For the small-scale isolation of an enriched mitochon-
drial fraction, the Mitoiso2 kit for cultured cells (Sigma-Aldrich, Taufkirchen, Germany) was used according to 
the manufacturer’s protocol. All experiments were performed according to the “homogenization” method. The 
first “heavy” mitochondrial fraction was obtained by centrifugation at 3,500 g, and the remaining supernatant was 
then centrifuged at 11,000 g, yielding the “light” mitochondrial fraction. The obtained fractions were analysed 
by Western blotting either with the antibody recognizing native SLC41A3 or with the antibody directed against 
the Strep tag as described previously. RPL19 (mouse anti-RPL19, Abnova, Heidelberg, Germany) was used as a 
cytosolic marker protein and cytochrome c oxidase (rabbit anti-CoxIV, Cell Signaling Technology, Frankfurt, 
Germany) as a mitochondrial marker. Secondary antibodies were the same as those mentioned above.
Fluorescence microscopy. Cells were grown on glass coverslips in 12-well plates. At 80% confluence, pro-
tein expression was induced by the addition of tetracycline. At 24 hours after induction, cells were treated 15 min-
utes with 4% paraformaldehyde and then washed 3 times in PBS. Blocking was performed with 10% normal goat 
serum (NGS) in PBS for 1 hour. The cells were then incubated for 1 hour with the primary antibody against native 
SLC41A3 diluted 1:500 in 1% NGS, washed three times in PBS and finally incubated 1 hour with a goat anti-rabbit 
secondary antibody labelled with Alexa red-fluorescent dye (excitation at 561 or 594 nm) at a dilution of 1:500 
in 1% NGS. Subsequently, the cells were incubated with a primary antibody against the mitochondrial protein 
COX IV diluted 1:200, washed three times in PBS and then incubated with a goat anti-mouse secondary antibody 
labelled with Alexa green-fluorescent dye (excitation at 488 nm) at a dilution of 1:500 in 1% NGS.
Double-stain immunofluorescence was performed also with the two primary antibodies anti-Strep (1:500) 
and anti-COX IV (1:1000) with the respective secondary antibodies conjugated to Alexa green-fluorescent and 
Alexa red-fluorescent dyes.
Another aliquot of cells were immunostained with a primary antibody against Strep-tagged SLC41A3 (1:500) 
and a secondary goat anti-mouse antibody (1:500), followed by an incubation with the primary antibody specific 
for the Golgi marker protein Golgin-97 (1:100) or the ER marker protein ERp72 (1:100) followed by a secondary 
goat anti-rabbit antibody (1:500).
Finally the cells were washed in PBS. The coverslips were mounted with the mounting medium Fluoroshield 
with DAPI (Sigma-Aldrich, Munich, Germany) to visualize cell nuclei and inverted onto glass slides suitable for 
microscopy. Digital images were acquired with an automated inverted microscope (Leica DMI 6000 B) and ana-
lysed with the microscope imaging software Las AF (Leica).
Quantification of intracellular Mg2+. In order to characterize the Mg2+ transport activity of SLC41A3, 
the Mg2+-sensitive fluorescent dye mag-fura 2 was used under influx or efflux conditions. [Mg2+]i was determined 
by measuring the fluorescence of the mag-fura-2-loaded cells in an LS55 spectrofluorometer (PerkinElmer) 
by using the fast filter application with alternating excitation at 340 nm and 380 nm and emission at 515 nm. 
SLC41A3-HEK cells (stably transfected) were grown to 80% confluence; protein expression was induced by the 
addition of tetracycline (tet, 1 μ g/mL) for 24 hours. Subsequently, cells were gently scraped, washed in Ca2+- and 
Mg2+-free HBSS (137 mM NaCl; 5.36 mM KCl; 0.34 mM Na2HPO4; 0.44 mM KH2HPO4; 5.55 mM glucose; 
4.17 mM NaHCO3, 20 mM Hepes) and then loaded for 20 min with mag-fura 2 AM (7.5 μ M) on a shaking plate 
at 37 °C. Following mag-fura 2 loading, the cells were incubated for another 20 min at 37 °C in HBSS to allow the 
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complete de-esterification of the fluorescent probe, washed twice with HBSS to remove extracellular mag-fura 
2, and resuspended in completely Mg2+- and Ca2+-free HBSS. Measurements of Mg2+ influx were performed at 
37 °C in 3-ml cuvettes containing 2 ml cell suspension that was constantly stirred. Extracellular Mg2+ was added 
stepwise at increasing concentrations, ranging from 1 to 5 mM, during the measurement. For the Mg2+ efflux 
experiments, the cells were incubated with 10 mM MgCl2 at 37 °C for 20 min after mag-fura 2 loading, washed 
twice in Mg2+- and Ca2+-free HBSS, and finally measured in Mg2+- and Ca2+-free HBSS at 37 °C in 3-ml cuvettes.
Large-scale isolation of mitochondria for mag-fura 2 measurements. Cells were harvested in 
ice-cold PBS, centrifuged, and washed in ice-cold isolation buffer (IB; 210 mM Mannitol, 70 mM sucrose, 5 mM 
Hepes-KOH pH 7.2, and 0.5% BSA). The cell pellet was resuspended (4 mL IB/g cells), and digitonin (10 mg/mL 
in DMSO) was added stepwise to permeabilise the cells. The permeabilisation efficiency was controlled by trypan 
blue staining. After sufficient permeabilisation was reached, 5 ml IB was added, and the suspension was centri-
fuged (3,000 g, 5 min, 4 °C). The pellet was resuspended in IB, and the suspension was homogenized by using a 
Dounce homogenizer. IB without BSA (3 times the volume of the homogenate) was added, and unbroken cells 
and cell debris were pelleted by centrifugation (1,200 g, 3 min, 4 °C). This clarifying step was repeated once before 
the suspension was finally centrifuged (10,000 g, 20 min, 4 °C) to pellet the mitochondria. The mitochondrial 
pellet was resuspended in 1 mL IB without BSA supplemented with 0.5 mM ATP, 0.2% succinate, and 0.01% 
pyruvate.
Quantification of free magnesium in mitochondria. Mitochondria were loaded with mag-fura 2 
AM (7.5 μ M) for 20 min on a shaking plate at 37 °C in IB without BSA+ S (S: supplemented with 0.5 mM ATP, 
0.2% succinate, and 0.01% pyruvate). Following mag-fura 2 loading, mitochondria were incubated in IB with-
out BSA+ S with 10 mM MgCl2 at 37 °C for 20 min (mag-fura 2 AM activation) and then washed twice in Mg2+ 
and Ca2+-free IB without BSA+ S. Finally, [Mg2+]i was determined in IB without BSA+ S supplemented with 
10 mM NaCl in an LS55 spectrofluorometer as described above. The osmolarity of the HBSS measurement buffer 
solutions with various NaCl concentrations or NMDG-Cl was controlled and maintained between 290 and 300 
mosmol/L. Imipramine was dissolved in water and added to give a final concentration of 250 μ M during the dye 
activation step and the measurements. Curves of representative recordings were smoothened with a “moving 
average” algorithm (Fs = 99; FL WinLab version 4.00.03).
Determination of relative cellular ATP levels. A luminescence ATP detection assay kit (Abcam, 
Cambridge, UK) was used to determine relative cellular ATP levels in uninduced and induced A3st cells under 
various growth conditions. Cells were seeded in duplicate in 24-well plates at a starting density of 8000 cells/well 
in glucose/glutamine-free DMEM medium (Biochrom, Berlin, Germany). The medium was supplemented with 
5 mM D-galactose, 6 mM L-glutamine, 1 mM sodium pyruvate, 10% dialyzed FBS, 15 μ g/mL Bla, and 100 μ g/mL 
Hyg. Cells were cultured for 24 hours, and then expression of A3 was induced by addition of tetracycline. Control 
cells were left untreated. After 24 hours the medium was exchanged either against Mg2+-free HBSS medium 
(1x HBSS salts, 5 mM D-galactose, 6 mM L-glutamine, 1 mM sodium pyruvate, 10% dialyzed FBS, 15 μ g/mL Bla, 
and 100 μ g/mL Hyg) or HBSS medium (same composition as above) but supplemented with 0.8 mM MgSO4. 
Control cells remained in the aforementioned DMEM medium. After another 6 hours of incubation the ATP 
assay was performed as follows. Two-hundred μ l of the supplied detergent solution was directly added to the 
medium and the plate was incubated for 5 min in an orbital shaker. Then 200 μ l of substrate solution was added 
to each well and the plate was incubated for another 5 min under constant shaking. The suspension of each well 
was then transferred to four wells of a 96 well plate (200 μ l each) and after 10 min of dark adaptation luminescence 
was measured with an EnSpire multimode plate reader (PerkinElmer). Results were blank corrected against wells 
without cells but containing medium, detergent and substrate solution. The experiment was performed two times.
Statistical analyses. (1) A two-tailed Student’s t-test was used to compare the differences between two 
means (i.e., influx in induced and uninduced cells, Fig. 3b). (2) A post hoc Holm-Sidak one-factor ANOVA (all 
pairwise multiple comparison) was used when three or more groups were compared (i.e., efflux experiments in 
induced and uninduced stable and transient cell lines in Fig. 2 or mitochondrial efflux, Fig. 7a). (3) A post hoc 
Dunn’s one-factor ANOVA (multiple comparisons versus control group) was used when three or more groups 
were compared with a control (i.e., mitochondria efflux under various NaCl concentrations or temperature con-
ditions, Fig. 8). (4) A post hoc Holm-Sidak two-factor ANOVA (all pairwise multiple comparison) was used to 
compare 2 factorial data sets (i.e., tet x different media for the determination of cellular ATP levels, Supplemental 
Fig. S5).
A Shapiro-Wilk normality test was used for (1), (2) and (3). Data are presented as means ± SE. Differences of 
P < 0.05 were considered significant. Statistical analyses were executed by using SigmaPlot 11.0 (Systat Software, Inc.).
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